Lucile Packard Children's Hospital
16
1
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
25.0%
4 terminated/withdrawn out of 16 trials
63.6%
-22.9% vs industry average
0%
0 trials in Phase 3/4
100%
7 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Role: collaborator
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
Role: collaborator
Implementation of Red Blood Cell Transfusion Recommendations in the Pediatric Intensive Care Unit
Role: collaborator
The Utility of Virtual Reality in the Management of Pediatric Functional Constipation With Pelvic Floor Dysfunction.
Role: collaborator
DVD-Based Training Program in Self-Hypnosis for Children
Role: collaborator
Pedometer Use to Prevent Excessive Pregnancy Weight Gain in Overweight Women
Role: collaborator
Home or Away From Home - Descriptive Interviews (Aim 2)
Role: collaborator
Home Away From Home - Medical Outcomes
Role: collaborator
Home Away From Home - Quality of Life Surveys
Role: collaborator
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
Role: collaborator
Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
Role: collaborator
Long-term Outcomes and Vascular Evaluation After Coarctation of the Aorta Treatment
Role: collaborator
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Role: collaborator
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
Role: collaborator
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
Role: collaborator
IIPE-PRIS Accelerating Safe Signouts
Role: collaborator
All 16 trials loaded